Lisa Hook - Philip Morris Independent Director
| PM Stock | USD 133.06 1.24 0.94% |
Director
Ms. Lisa Hook is an Independent Director of the Company. Ms. Hook served as Chief Executive Officer of Neustar, Inc. from October 2010, as a member of its Board from November 2010, and as President from January 2008. She retired from Neustar in July 2018 since 2018.
| Age | 63 |
| Tenure | 6 years |
| Address | 677 Washington Boulevard, Stamford, CT, United States, 06901 |
| Phone | 203 905 2410 |
| Web | https://www.pmi.com |
Philip Morris Management Efficiency
The company has Return on Asset (ROA) of 0.1312 % which means that for every $100 of assets, it generated a profit of $0.1312. This is way below average. Philip Morris' management efficiency ratios could be used to measure how well Philip Morris manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Philip Morris' Return On Tangible Assets are very stable compared to the past year. As of the 30th of November 2024, Return On Capital Employed is likely to grow to 0.38, though Return On Equity is likely to grow to (0.66). At this time, Philip Morris' Asset Turnover is very stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Debra KellyEnnis | Altria Group | 64 | |
| Nabil Sakkab | Altria Group | 74 | |
| Thomas Johnson | Universal | 70 | |
| Assia GrazioliVenier | Turning Point Brands | 40 | |
| Theodore Broome | Universal | 70 | |
| Peter Durman | Imperial Brands PLC | N/A | |
| Dimitri Panayotopoulos | British American Tobacco | 69 | |
| Arnold Zimmerman | Turning Point Brands | 83 | |
| Jack Bowles | British American Tobacco | 60 | |
| Luc Jobin | British American Tobacco | 61 | |
| Johan Vandermeulen | British American Tobacco | 56 | |
| Jerome Abelman | British American Tobacco | 60 | |
| Kingsley Wheaton | British American Tobacco | 51 | |
| Stephen Usher | Turning Point Brands | 54 | |
| Gregory Baxter | Turning Point Brands | 67 | |
| Marion Helmes | British American Tobacco | 55 | |
| Diana Cantor | Universal | 62 | |
| John Charnovich | Turning Point Brands | 63 | |
| Ashley Frushone | Turning Point Brands | 46 | |
| John Casteen | Altria Group | 77 | |
| Susan Farr | British American Tobacco | 64 | |
Management Performance
| Return On Asset | 0.13 |
Philip Morris Intern Leadership Team
Elected by the shareholders, the Philip Morris' board of directors comprises two types of representatives: Philip Morris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Philip. The board's role is to monitor Philip Morris' management team and ensure that shareholders' interests are well served. Philip Morris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Philip Morris' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emmanuel Babeau, Chief Financial Officer | ||
| Andre Calantzopoulos, Chief Executive Officer, Director | ||
| Silke Muenster, Chief Diversity Officer | ||
| Paul Riley, President - East Asia and Australia Region | ||
| Jacek Olczak, Chief Executive Officer, Director | ||
| Jun Makihara, Independent Director | ||
| Prof Peitsch, Chief Officer | ||
| Charles Bendotti, Senior Vice President - People and Culture | ||
| Lisa Hook, Independent Director | ||
| Dessislava Temperley, Independent Director | ||
| Miroslaw Zielinski, President of Reduced-Risk Products | ||
| Michael Voegele, Chief Information Officer and Chief Digital Officer | ||
| Bonin Bough, Independent Director | ||
| Jerry Whitson, Deputy General Counsel, Corporate Secretary | ||
| Suzanne Folsom, Senior Vice President General Counsel | ||
| Shlomo Yanai, Independent Director | ||
| Drago Azinovic, President - Middle East and Africa Region and PMI Duty Free | ||
| Werner Geissler, Independent Director | ||
| Scott Coutts, Senior Operations | ||
| Moira Gilchrist, Chief Officer | ||
| Louis Camilleri, Non-Executive Chairman of the Board | ||
| Martin King, Chief Executive Officer- PMI America | ||
| Ankur Modi, Global Head - Strategy & Program Delivery | ||
| Jorge Insuasty, President Vectura Fertin Pharma and Chief Life Sciences Officer | ||
| Jorge MD, Chief Officer | ||
| John OMullane, Chief Life Sciences Officer | ||
| Marc Firestone, President - External Affairs, General Counsel | ||
| Jennifer Li, Independent Director | ||
| Michael Kunst, Senior Vice President - Commercial Transformation | ||
| Juan Daboub, Independent Director | ||
| Michel Combes, Independent Director | ||
| Lucio Noto, Interim Independent Chairman of the Board | ||
| Yann Guerin, Senior Counsel | ||
| Jaime Suarez, Chief Digital Officer | ||
| Frederik Paulsen, Independent Director | ||
| Frank Rooij, Vice President Treasury and Corporate Finance | ||
| Deepak Mishra, President of Americas Region | ||
| Massimo Andolina, Senior Vice President - Operations | ||
| Robert Polet, Independent Director | ||
| Werner Barth, President Combustibles Category & Global Combustibles Marketing | ||
| Mario Masseroli, Corporate Executive - Latin America and Canada Region | ||
| Stefano Volpetti, President Smoke-Free Products Category and Chief Consumer Officer | ||
| Kalpana Morparia, Independent Director | ||
| James Bushnell, Vice Communications | ||
| Andreas Kurali, Deputy Chief Financial Officer, Head of Finance Transformation | ||
| Marian Salzman, Senior Vice President - Global Communications | ||
| Bin Li, Chief Product Officer | ||
| Marco Mariotti, Senior Vice President - Corporate Affairs | ||
| Stacey Kennedy, President - South & Southeast Asia Region, Indonesia and Philippines | ||
| Reginaldo Dobrowolski, Vice President Controller | ||
| Frederic Wilde, Senior Vice President - Marketing and Sales | ||
| Gregoire Verdeaux, Senior Vice President - External Affairs |
Philip Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Philip Morris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.26 % | ||||
| Operating Margin | 0.43 % | ||||
| Current Valuation | 251.85 B | ||||
| Shares Outstanding | 1.55 B | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 80.43 % | ||||
| Number Of Shares Shorted | 8.33 M | ||||
| Price To Earning | 17.73 X | ||||
| Price To Sales | 5.56 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Philip Morris International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Tobacco space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Philip Morris. If investors know Philip will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Philip Morris listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.493 | Dividend Share 5.25 | Earnings Share 6.3 | Revenue Per Share 23.958 | Quarterly Revenue Growth 0.084 |
The market value of Philip Morris Intern is measured differently than its book value, which is the value of Philip that is recorded on the company's balance sheet. Investors also form their own opinion of Philip Morris' value that differs from its market value or its book value, called intrinsic value, which is Philip Morris' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Philip Morris' market value can be influenced by many factors that don't directly affect Philip Morris' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Philip Morris' value and its price as these two are different measures arrived at by different means. Investors typically determine if Philip Morris is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Philip Morris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.